Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Behnke M, Smith VC,, Committee on Substance A, Committee on F. Newborn 2013 prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics 2013;131:e1009–24.
Galball M, Spigset O, Johnson AR, Kohan R, Lappas M, Lewis AJ . Neonatal adaptation following intrauterine antidepressant exposure: assessment, drug assay levels and infant development outcomes. Pediatr Res, (e-pub ahead of print 16 August, 2017).
Holmes LB, Harvey EA, Coull BA et al, The teratogenicity of anticonvulsant drugs. N Engl J Med 2001;344:1132–8.
Olney JW, Young C, Wozniak DF, Jevtovic-Todorovic V, Ikonomidou C . Do pediatric drugs cause developing neurons to commit suicide? Trends Pharmacol Sci 2004;25:135–9.
Grossman MR, Berkwitt AK, Osborn RR et al, An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics 2017;139:6:2017:e20163360, E1-E9.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Rivkees, S., Denne, S. & On behalf of the Pediatric Policy Council. Influences of medications on the developing fetus: toward deciphering the unknowns. Pediatr Res 82, 723–724 (2017). https://doi.org/10.1038/pr.2017.199
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/pr.2017.199
This article is cited by
-
The assessment of drug safety for the fetus
International Journal of Clinical Pharmacy (2020)